Internal Medicine
RSSArticles
-
Reduce the Risk of Autoimmune Disease with Vitamin D, n-3 Fatty Acid Supplements
A randomized, controlled trial that included older adults showed vitamin D3 2,000 units daily or n-3 fatty acids 1,000 mg daily over five years reduced the incidence of autoimmune diseases 25% to 30%.
-
Looking Back, COVID-19 Vaccination Woes Were Predictable
Efficacy, protection duration, side effects, and FDA approval factored into decisions about choosing a COVID-19 vaccine.
-
Fluvoxamine Reduces the Risk for Hospitalization from COVID-19
Researchers found fluvoxamine (100 mg twice a day for 10 days) lowered the risk for hospitalization among high-risk outpatients diagnosed with COVID-19.
-
Researchers: Emergency Providers Missing Chances to Avert Future Opioid Disasters
Investigators express concern about prescribing rates for medication-assisted treatment after ED visits for opioid overdoses recorded between late 2019 and early 2021.
-
Is a New Right Bundle Branch Block a Sign of Coronary Artery Disease?
For asymptomatic subjects without known cardiac or renal disease, coronary lesions by CT angiography are more frequent in those with right bundle branch block vs. those without.
-
How an Influenza Vaccine Can Affect Cardiovascular Disease
A randomized, controlled trial of influenza vaccine vs. placebo in patients with acute myocardial infarction or at high risk for coronary artery disease inoculated during the index hospitalization showed a lower risk of the combined endpoint of death, myocardial infarction, or stent thrombosis at one year.
-
Earlier Coronary Artery Bypass Grafting After Ticagrelor Discontinuation Is Safe
In a trial that included acute coronary syndrome patients treated with ticagrelor, undergoing coronary bypass surgery within two to three days was noninferior to the guideline-recommended five to seven days regarding severe bleeding.
-
Pharmacotherapy for Atrial Fibrillation with Anticoagulation-Associated Intracranial Hemorrhage
A study of apixaban vs. no anticoagulation in patients following an anticoagulant for atrial fibrillation-related intracerebral hemorrhage exhibited a high risk of stroke and vascular death, regardless of whether the patients were treated subsequently with apixaban.
-
Role of Beta-Blockers in Heart Failure with Preserved Ejection Fraction
Discontinuation of beta-blockers in heart failure with preserved ejection fraction patients significantly improved quality of life scores and expanded exercise capacity.
-
Tailoring Dietary Recommendations to Protect Cognitive Health
Preventing inflammation as patients age is becoming key focus of lowering dementia risk.